The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | M | Musculo-skeletal system | |
| 2 | M04 | Antigout preparations | |
| 3 | M04A | Antigout preparations | |
| 4 | M04AC | Preparations with no effect on uric acid metabolism |
| Code | Title | |
|---|---|---|
| M04AC01 | Colchicine | |
| M04AC02 | Cinchophen | |
| M04AC51 |
| Active Ingredient | Description | |
|---|---|---|
| Colchicine |
Colchicine is considered to act against the inflammatory response to urate crystals, by possibly inhibiting the migration of granulocytes into the inflamed area. Other properties of colchicine, such as interaction with the microtubules, could also contribute to the operation. Onset of action is approximately 12 hours after oral administration and is maximal after 1 to 2 days. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| COLCHICINA | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| COLCHICINE Tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
